Mercia Asset Management
VC Fund
Henley In Arden, United Kingdom
Mercia Asset Management is a VC fund in Henley In Arden focused on Software and Information Technology. Mercia Asset Management invest across four distinct asset classes of venture, private equity and debt, referred to as our ‘Complete Capital Solution.Mercia Asset Management ision is to be the first choice for investors, investees and employees and, by aspiring to be the first choice, we believe that Mercia will deliver superior returns for businessowners, shareholders and fund investors alike.
- Total investments:
- 112
- Last investment:
- Lead investor:
- 63%
- Fund size:
- $38M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Mercia Asset Management invests in
Stages Mercia Asset Management invests in
Countries Mercia Asset Management invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 20 contacts → | |||
Round size
- Seed
- $576k–$3.2M
- Series A
- $2.2M–$13M
- Venture - Series Unknown
- $659k–$12M
Investment Focus
Industry
- Software 22 (20%)
- Information Technology 14 (13%)
- Health Care 12 (11%)
- Manufacturing 9 (8%)
- Biotechnology 8 (7%)
Stage
- Venture - Series Unknown 23 (21%)
- Series A 18 (16%)
- Seed 17 (15%)
- Funding Round 10 (9%)
- Series B 6 (5%)
Country
- United Kingdom 63 (56%)
- United States 2 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Aaron Lawson-Clark
Investment Director
|
Investment Director | Total investments: 4 | Find email | |
Ashwin Kumaraswamy
Investment Director
|
Investment Director | Total investments: 4 | Find email | |
Brijesh Roy
Investment Manager
|
Investment Manager | Total investments: 3 | Find email | |
Clive Downward
Investment Director
|
Investment Director | Total investments: 0 | Find email | |
Graham Davies
Investment Director
|
Investment Director | Total investments: 1 | Find email | |
| See all 20 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| StratoBayes is a Durham University spin-out developing AI-powered subsurface decision intelligence. Its proprietary Bayesian AI helps geoscientists make faster and better-informed decisions by combining geological evidence with probabilistic reasoning and quantifying the uncertainty in every result. The technology has applications across energy,carbon capture and storage, geothermal, hydrogen storage, mining, critical minerals and infrastructure. The company's vision is to embed probabilistic reasoning into every subsurface workflow, building toward a foundation model of the subsurface, so that better decisions can be made wherever understanding the Earth's subsurface is critical. | Pre-Seed / Jul 14, 2026 | ||
| Warwick Acoustics is a UK-based technology company specialising in the development of HighRes Audio solutions for the automotive and headphone markets based on its patented High Precision Electrostatic Laminate technology (HPELs). Their ultra thin, lightweight HPELs deliver audiophile performance across a bandwidth several octaves greater thantraditional moving coil speakers in a form factor that is less than one quarter the weight, and one tenth of the thickness. In addition, HPELs offer designers unparalleled flexibility to shaped and form a speaker to individual design requirements. | $8.5M / Venture - Series Unknown / Jun 25, 2026 | ||
| Netacea offers a comprehensive bot management solution that safeguards enterprises from automated threats such as account takeover, credential stuffing, and web scraping. By utilizing behavior-based detection and machine learning, the platform operates seamlessly across websites, mobile apps, and APIs, enhancing operational efficiency and customerexperience. | $5.1M / Series A / Dec 06, 2024 | ||
| Semble is a healthcare technology company that develops practice management and electronic health record software for private healthcare providers. The company offers an integrated platform that combines patient records, appointment scheduling, telehealth, billing, payments, clinical documentation, prescribing, and care coordination tools within asingle system. Its software is designed to support the delivery and administration of healthcare services across clinics, medical practices, and multi-site healthcare organizations. The platform enables healthcare professionals to manage patient journeys from initial booking through consultation, treatment, follow-up care, and payment processing. It includes electronic health record functionality, clinical note management, patient communication tools, online booking capabilities, and workflow automation features that help streamline administrative and clinical processes.In addition to clinical and administrative functions, the company offers analytics, reporting, patient engagement, and automation tools that help healthcare organizations manage operations and monitor performance. Its solutions are used by a range of healthcare providers, including physicians, specialists, mental health professionals, physiotherapists, pharmacies, and occupational health organizations. | $15M / Series B / Oct 23, 2024 | ||
| Locate Bio is a regenerative medicine development company focused on orthobiologics. Locate Bio exists to help surgeons improve the lives of people with debilitating spinal conditions. We are curious about what is possible, but ground all our work in robust scientific evidence. We relentlessly pursue high-value opportunities with clear unmetclinical needs. | $11.6M / Venture - Series Unknown / Apr 29, 2024 | ||
| Thalia Design Automation Ltd. operates as a semiconductor electronic design automation (EDA) company that provides software solutions to assist in the design of analog and mixed signal integrated circuits. | $2.7M / Jul 19, 2023 | ||
| The One Point specializes in business mobiles, VoIP, broadband, IT support, printing, CRM, e-commerce and mobile app development services. | $1.8M / Debt Financing / Jul 11, 2023 | ||
| Camena Bioscience is a synthetic biology company that develops tools to engineer new synthetic biology applications. It has engineered new nucleic acid synthesis technology which improves the quality and speed of synthesis. Its multi-enzymatic technology takes one approach to DNA, RNA, and XNA synthesis, offering increased accuracy over existingPhosphoramidite synthesis technology.Camena Bioscience was founded in 2016 and is headquartered in Cambridge. | $10.3M / Series A / Jul 03, 2023 | ||
| Medherant was founded by Professor David Haddleton and the University of Warwick to develop and commercialise novel transdermal drug delivery platforms. Current patch technologies have limited drug loading capabilities, making them unviable for use with many pharmaceutical products that could benefit from transdermal delivery. Creams and gels onthe other hand suffer from a lack of dose control that is critical for many drugs. | $3.6M / Venture - Series Unknown / Apr 03, 2023 | ||
| Newcells Biotech are experts in the production of induced pluripotent stem cells (iPSCs) and their differentiation into a wide range of reliable and reproducible cell and tissue types. Their focus is to provide customers engaged in drug discovery, pre-clinical development and disease mechanism investigation, with the best quality cells andservices. | $6.1M / Series A / Mar 16, 2023 | ||
| See all 112 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Mercia Asset Management invest in?
Mercia Asset Management invests primarily in Software, Information Technology and Health Care startups, most often at Venture - Series Unknown and Series A stage. Most of the 112 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Mercia Asset Management's check size?
Mercia Asset Management typically joins rounds of $576k–$3.2M at Seed, $2.2M–$13M at Series A and $659k–$12M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Mercia Asset Management participates in.
How do I contact Mercia Asset Management?
Public channels for Mercia Asset Management include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Mercia Asset Management?
The team at Mercia Asset Management includes Aaron Lawson-Clark (Investment Director), Ashwin Kumaraswamy (Investment Director) and Brijesh Roy (Investment Manager), among 20 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
